- Home
- CPHI vs BGMS Comparison
CPHI vs BGMS Comparison
Compare CPHI & BGMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CPHI | BGMS |
|---|---|---|
| Founded | N/A | 1996 |
| Country | China | Malaysia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1M | 5.0M |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | CPHI | BGMS |
|---|---|---|
| Price | $0.61 | $1.04 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 77.1K | ★ 146.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 70.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,528,929.00 | N/A |
| Revenue This Year | N/A | $137.21 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.12 | $0.74 |
| 52 Week High | $14.00 | $6.70 |
Technical Indicators
Market Signals| Indicator | CPHI | BGMS |
|---|---|---|
| Relative Strength Index (RSI) | 22.72 | 45.25 |
| Support Level | $0.60 | $0.98 |
| Resistance Level | $0.69 | $1.06 |
| Average True Range (ATR) | 0.12 | 0.13 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 4.43 | 58.21 |
Price Performance
Historical ComparisonAbout CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.
About BGMS Bio Green Med Solution Inc.
Bio Green Med Solution Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.